 | • レポートコード：20QY06-03026 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒュミラのグローバル市場について種類別（ヒュミラシリンジ、ヒュミラペン）、用途別（強直性脊椎炎、関節リウマチ、クローン病、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒュミラ市場の概要 ・世界の主要地域別ヒュミラ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒュミラ市場規模2015-2026：種類別（ヒュミラシリンジ、ヒュミラペン） ・世界のヒュミラ市場規模2015-2026：用途別（強直性脊椎炎、関節リウマチ、クローン病、その他） ・ヒュミラの北米市場規模2015-2020 ・ヒュミラのヨーロッパ市場規模2015-2020 ・ヒュミラの中国市場規模2015-2020 ・ヒュミラの日本市場規模2015-2020 ・ヒュミラの東南アジア市場規模2015-2020 ・ヒュミラのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AbbVie、Eisai、Cadila Healthcare、Torrent Pharmaceuticals、Amgen、Boehringer Ingelheim） ・ヒュミラの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒュミラの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Humira Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Humira market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn’s disease or juvenile idiopathic arthritis.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Humira market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Humira industry.
Based on our recent survey, we have several different scenarios about the Humira YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 12050 million in 2019. The market size of Humira will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Humira market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Humira market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Humira market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Humira market. The report also includes nautical information, where it shows Humira market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Humira market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Humira market.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion in 2017 is about 43%, and the proportion is in decreasing trend from 2013 to 2017.
USA is the largest market, with a sales market share nearly 65% in 2017. Following USA, Europe is the second largest market with the sales market share of 30%.
Geographical Analysis:
Based on region, the global Humira market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Humira market are
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
…
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Humira market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Humira market.
• The market share of the global Humira market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Humira market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Humira market.
1 Humira Market Overview
1.1 Humira Product Scope
1.2 Humira Segment by Type
1.2.1 Global Humira Sales by Type (2020-2026)
1.2.2 Humira Syringe
1.2.3 Humira Pen
1.3 Humira Segment by Application
1.3.1 Global Humira Sales Comparison by Application (2020-2026)
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn’s Disease
1.3.5 Other
1.4 Humira Market Estimates and Forecasts (2015-2026)
1.4.1 Global Humira Sales Growth Rate (2015-2026)
1.4.2 Global Humira Revenue and Growth Rate (2015-2026)
1.4.3 Global Humira Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Humira Industry Impact
1.5.1 How the Covid-19 is Affecting the Humira Industry
1.5.1.1 Humira Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Humira Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Humira Players to Combat Covid-19 Impact
2 Humira Estimate and Forecast by Region
2.1 Global Humira Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Humira Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Humira Sales Market Share by Region (2015-2020)
2.2.2 Global Humira Revenue Market Share by Region (2015-2020)
2.3 Global Humira Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Humira Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Humira Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Humira Estimates and Projections (2015-2026)
2.4.2 Europe Humira Estimates and Projections (2015-2026)
2.4.3 China Humira Estimates and Projections (2015-2026)
2.4.4 Japan Humira Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Humira Estimates and Projections (2015-2026)
2.4.6 India Humira Estimates and Projections (2015-2026)
3 Global Humira Competition Landscape by Players
3.1 Global Top Humira Players by Sales (2015-2020)
3.2 Global Top Humira Players by Revenue (2015-2020)
3.3 Global Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humira as of 2019)
3.4 Global Humira Average Price by Company (2015-2020)
3.5 Manufacturers Humira Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Humira Players (Opinion Leaders)
4 Global Humira Market Size by Type
4.1 Global Humira Historic Market Review by Type (2015-2020)
4.1.1 Global Humira Sales Market Share by Type (2015-2020)
4.1.2 Global Humira Revenue Market Share by Type (2015-2020)
4.1.3 Global Humira Price by Type (2014-2020)
4.2 Global Humira Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Humira Sales Forecast by Type (2021-2026)
4.2.2 Global Humira Revenue Forecast by Type (2021-2026)
4.2.3 Global Humira Price Forecast by Type (2021-2026)
5 Global Humira Market Size by Application
5.1 Global Humira Historic Market Review by Application (2015-2020)
5.1.1 Global Humira Sales Market Share by Application (2015-2020)
5.1.2 Global Humira Revenue Market Share by Application (2015-2020)
5.1.3 Global Humira Price by Application (2015-2020)
5.2 Global Humira Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Humira Sales Forecast by Application (2021-2026)
5.2.2 Global Humira Revenue Forecast by Application (2021-2026)
5.2.3 Global Humira Price Forecast by Application (2021-2026)
3 North America Humira Market Facts & Figures
3.2 North America Humira Sales Market Share by Company (2015-2020)
3.3 North America Humira Sales Market Share by Type (2015-2020)
3.4 North America Humira Sales Market Share by Application (2015-2020)
4 Europe Humira Market Facts & Figures
4.2 Europe Humira Sales Market Share by Company (2015-2020)
4.3 Europe Humira Sales Market Share by Type (2015-2020)
4.4 Europe Humira Sales Market Share by Application (2015-2020)
5 China Humira Market Facts & Figures
5.2 China Humira Sales Market Share by Company (2015-2020)
5.3 China Humira Sales Market Share by Type (2015-2020)
5.4 China Humira Sales Market Share by Application (2015-2020)
6 Japan Humira Market Facts & Figures
6.2 Japan Humira Sales Market Share by Company (2015-2020)
6.3 Japan Humira Sales Market Share by Type (2015-2020)
6.4 Japan Humira Sales Market Share by Application (2015-2020)
7 Southeast Asia Humira Market Facts & Figures
7.2 Southeast Asia Humira Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Humira Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Humira Sales Market Share by Application (2015-2020)
8 India Humira Market Facts & Figures
8.2 India Humira Sales Market Share by Company (2015-2020)
8.3 India Humira Sales Market Share by Type (2015-2020)
8.4 India Humira Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Humira Business
12.1 AbbVie
12.1.1 AbbVie Humira Corporation Information
12.1.2 AbbVie Humira Business Overview and Total Revenue
12.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AbbVie Humira Products Offered
12.1.5 AbbVie Recent Development
12.2 Eisai
12.2.1 Eisai Humira Corporation Information
12.2.2 Eisai Humira Business Overview and Total Revenue
12.2.3 Eisai Humira Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai Humira Products Offered
12.2.5 Eisai Recent Development
12.3 Cadila Healthcare
12.3.1 Cadila Healthcare Humira Corporation Information
12.3.2 Cadila Healthcare Humira Business Overview and Total Revenue
12.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cadila Healthcare Humira Products Offered
12.3.5 Cadila Healthcare Recent Development
12.4 Torrent Pharmaceuticals
12.4.1 Torrent Pharmaceuticals Humira Corporation Information
12.4.2 Torrent Pharmaceuticals Humira Business Overview and Total Revenue
12.4.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Torrent Pharmaceuticals Humira Products Offered
12.4.5 Torrent Pharmaceuticals Recent Development
12.5 Amgen
12.5.1 Amgen Humira Corporation Information
12.5.2 Amgen Humira Business Overview and Total Revenue
12.5.3 Amgen Humira Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Humira Products Offered
12.5.5 Amgen Recent Development
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Humira Corporation Information
12.6.2 Boehringer Ingelheim Humira Business Overview and Total Revenue
12.6.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer Ingelheim Humira Products Offered
12.6.5 Boehringer Ingelheim Recent Development
…
13 Humira Manufacturing Cost Analysis
13.1 Humira Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Humira
13.4 Humira Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Humira Distributors List
14.3 Humira Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Humira Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Humira Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Humira Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Humira Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Humira Players to Combat Covid-19 Impact
Table 8. Global Market Humira Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Humira Sales (K Units) by Region (2015-2020)
Table 10. Global Humira Sales Market Share by Region (2015-2020)
Table 11. Global Humira Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Humira Revenue Share by Region (2015-2020)
Table 13. Global Humira Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Humira Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Humira Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Humira Revenue Share Forecast by Region (2021-2026)
Table 17. Global Humira (K Units) of Key Companies (2015-2020)
Table 18. Global Humira Sales Share by Company (2015-2020)
Table 19. Global Humira Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Humira Revenue Share by Company (2015-2020)
Table 21. Global Humira by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humira as of 2019)
Table 22. Global Humira Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Humira Manufacturing Sites and Area Served
Table 24. Manufacturers Humira Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Humira Players
Table 27. Global Humira Sales (K Units) by Type (2015-2020)
Table 28. Global Humira Sales Share by Type (2015-2020)
Table 29. Global Humira Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Humira Price (K Units) by Type (2015-2020)
Table 31. Global Humira Sales Share by Type (2021-2026)
Table 32. Global Humira Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Humira Revenue Share by Type (2021-2026)
Table 34. Global Humira Price (K Units) by Type (2021-2026)
Table 35. Global Humira Sales (K Units) by Application (2015-2020)
Table 36. Global Humira Sales Share by Application (2015-2020)
Table 37. Global Humira Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Humira Price (K Units) by Application (2015-2020)
Table 39. Global Humira Sales (K Units) by Application (2021-2026)
Table 40. Global Humira Sales Share by Application (2021-2026)
Table 41. Global Humira Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Humira Revenue Share by Application (2021-2026)
Table 43. Global Humira Price (K Units) by Application (2021-2026)
Table 44. United States Humira Sales (K Units) by Company (2015-2020)
Table 45. United States Humira Sales Market Share by Company (2015-2020)
Table 46. United States Humira Sales (K Units) by Type (2015-2020)
Table 47. United States Humira Sales Market Share by Type (2015-2020)
Table 48. United States Humira Sales (K Units) by Application (2015-2020)
Table 49. United States Humira Sales Market Share by Application (2015-2020)
Table 50. Europe Humira Sales (K Units) by Company (2015-2020)
Table 51. Europe Humira Sales Market Share by Company (2015-2020)
Table 52. Europe Humira Sales (K Units) by Type (2015-2020)
Table 53. Europe Humira Sales Market Share by Type (2015-2020)
Table 54. Europe Humira Sales (K Units) by Application (2015-2020)
Table 55. Europe Humira Sales Market Share by Type (2015-2020)
Table 56. China Humira Sales (K Units) by Company (2015-2020)
Table 57. China Humira Sales Market Share by Company (2015-2020)
Table 58. China Humira Sales (K Units) by Type (2015-2020)
Table 59. China Humira Sales Market Share by Type (2015-2020)
Table 60. China Humira Sales (K Units) by Application (2015-2020)
Table 61. China Humira Sales Market Share by Application (2015-2020)
Table 62. Japan Humira Sales (K Units) by Company (2015-2020)
Table 63. Japan Humira Sales Market Share by Company (2015-2020)
Table 64. Japan Humira Sales (K Units) by Type (2015-2020)
Table 65. Japan Humira Sales Market Share by Type (2015-2020)
Table 66. Japan Humira Sales (K Units) by Application (2015-2020)
Table 67. Japan Humira Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Humira Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Humira Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Humira Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Humira Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Humira Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Humira Sales Market Share by Application (2015-2020)
Table 74. India Humira Sales (K Units) by Company (2015-2020)
Table 75. India Humira Sales Market Share by Company (2015-2020)
Table 76. India Humira Sales (K Units) by Type (2015-2020)
Table 77. India Humira Sales Market Share by Type (2015-2020)
Table 78. India Humira Sales (K Units) by Application (2015-2020)
Table 79. India Humira Sales Market Share by Application (2015-2020)
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. AbbVie Humira Product
Table 84. AbbVie Recent Development
Table 85. Eisai Corporation Information
Table 86. Eisai Description and Business Overview
Table 87. Eisai Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Eisai Humira Product
Table 89. Eisai Recent Development
Table 90. Cadila Healthcare Corporation Information
Table 91. Cadila Healthcare Description and Business Overview
Table 92. Cadila Healthcare Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Cadila Healthcare Humira Product
Table 94. Cadila Healthcare Recent Development
Table 95. Torrent Pharmaceuticals Corporation Information
Table 96. Torrent Pharmaceuticals Description and Business Overview
Table 97. Torrent Pharmaceuticals Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Torrent Pharmaceuticals Humira Product
Table 99. Torrent Pharmaceuticals Recent Development
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Amgen Humira Product
Table 104. Amgen Recent Development
Table . Boehringer Ingelheim Corporation Information
Table . Boehringer Ingelheim Description and Business Overview
Table . Boehringer Ingelheim Humira Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Boehringer Ingelheim Humira Product
Table . Boehringer Ingelheim Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Humira Distributors List
Table 113. Humira Customers List
Table 114. Market Key Trends
Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 116. Key Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Humira Product Picture
Figure 2. Global Humira Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Humira Market Share by Application in 2020 & 2026
Figure 6. Ankylosing Spondylitis Examples
Figure 7. Rheumatoid Arthritis Examples
Figure 8. Crohn’s Disease Examples
Figure 9. Other Examples
Figure 10. Global Humira Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Humira Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Humira Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Humira Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Humira Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Humira Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Humira Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Humira Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Humira Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Humira Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Humira Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Humira Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Humira Players Market Share by Revenue in Humira 2015 & 2019
Figure 28. Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Humira Revenue Share by Type (2015-2020)
Figure 30. Global Humira Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Humira Revenue Share by Application (2015-2020)
Figure 32. Global Humira Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Humira Sales Market Share by Type in 2019
Figure 34. United States Humira Sales Market Share by Type in 2019
Figure 35. Europe Humira Sales Market Share by Company in 2019
Figure 36. Europe Humira Sales Market Share by Type in 2019
Figure 37. Europe Humira Sales Market Share by Application in 2019
Figure 38. China Humira Sales Market Share by Company in 2019
Figure 39. China Humira Sales Market Share by Type in 2019
Figure 40. China Humira Sales Market Share by Application in 2019
Figure 41. Japan Humira Sales Market Share by Company in 2019
Figure 42. Japan Humira Sales Market Share by Type in 2019
Figure 43. Japan Humira Sales Market Share by Application in 2019
Figure 44. Southeast Asia Humira Sales Market Share by Company in 2019
Figure 45. Southeast Asia Humira Sales Market Share by Type in 2019
Figure 46. Southeast Asia Humira Sales Market Share by Application in 2019
Figure 47. India Humira Sales Market Share by Company in 2019
Figure 48. India Humira Sales Market Share by Type in 2019
Figure 49. India Humira Sales Market Share by Application in 2019
Figure 50. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cadila Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Torrent Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Humira
Figure 58. Manufacturing Process Analysis of Humira
Figure 59. Humira Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
腫瘍壊死因子アルファ阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tumor Necrosis Factor Alpha Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor …- インフリキシマブ・バイオシミラーの世界市場レポート2020 Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. Market Analysis and Insights: Global Infliximab and biosimilar Market The global Infliximab and biosimilar m…
- 関節リウマチ（RA）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Rheumatoid Arthritis (RA) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 21300 million by 2025, from USD 18600 million in 2019. The Rheuma…
- 浣腸注射器の世界市場レポート2020 Market Analysis and Insights: Global Enema Syringe Market The global Enema Syringe market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Enema Syringe Scope and Market Size The global Enema Syringe market is se…
- 耳シリンジの世界市場レポート2020 Ear Syringe is a simple pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube (called a barrel), allowing the Ear Syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. Ear Syringe are ofte…